• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

MicroRNA-124 通过靶向 STAT3 抑制三阴性乳腺癌细胞的增殖和侵袭。

MicroRNA‑124 suppresses cell proliferation and invasion of triple negative breast cancer cells by targeting STAT3.

机构信息

Department of Thyroid and Breast Surgery, The Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430000, P.R. China.

Department of General Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430000, P.R. China.

出版信息

Mol Med Rep. 2019 May;19(5):3667-3675. doi: 10.3892/mmr.2019.10044. Epub 2019 Mar 15.

DOI:10.3892/mmr.2019.10044
PMID:30896795
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6472193/
Abstract

MicroRNAs (miRNAs) are pivotal regulators of the progression of carcinogenesis and negatively regulate the expression of tumour‑associated genes. Downregulation of miR‑124 expression has been demonstrated in various human cancer tissues, wherein miR‑124 serves as a tumour suppressor by targeting oncogenes. However, its function and underlying mechanism of action remain unclear in breast cancer. In the present study, the tissue‑specific expression of miR‑124 was detected in 10 paired triple‑negative breast cancer and normal tissues, and its inhibitory effects on cell growth and invasion were evaluated in vitro and in vivo. Bioinformatics analysis identified signal transducer and activator of transcription 3 (STAT3), a well‑known oncogene in breast cancer, as the potential target. Upregulation of miR‑124 expression decreased STAT3 mRNA and protein levels in breast cancer cells and the relative luciferase activity. Rescue experiments revealed that the transfection of a STAT3 expression plasmid reversed the inhibitory effect of miR‑124 on the proliferation and invasion of MDA‑MB‑468 cells. These data demonstrate that miR‑124 serves vital roles in the suppression of triple‑negative breast cancer via inhibition of cell proliferation and invasion through STAT3. These results highlight the potential role of miR‑124 as a diagnostic or therapeutic target in patients with breast cancer.

摘要

微小 RNA(miRNA)是致癌作用进展的重要调节因子,可负向调节肿瘤相关基因的表达。在各种人类癌症组织中已证实 miR-124 的表达下调,miR-124 通过靶向癌基因发挥肿瘤抑制作用。然而,其在乳腺癌中的功能及其潜在作用机制尚不清楚。在本研究中,检测了 10 对三阴性乳腺癌和正常组织中 miR-124 的组织特异性表达,并在体外和体内评估了其对细胞生长和侵袭的抑制作用。生物信息学分析鉴定信号转导和转录激活因子 3(STAT3)为潜在靶标,STAT3 是乳腺癌中众所周知的癌基因。miR-124 表达上调可降低乳腺癌细胞中 STAT3 mRNA 和蛋白水平及相对荧光素酶活性。挽救实验表明,STAT3 表达质粒的转染可逆转 miR-124 对 MDA-MB-468 细胞增殖和侵袭的抑制作用。这些数据表明,miR-124 通过抑制 STAT3 抑制三阴性乳腺癌的细胞增殖和侵袭,从而发挥重要作用。这些结果突出了 miR-124 作为乳腺癌患者诊断或治疗靶点的潜在作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e741/6472193/03f33afb7c75/MMR-19-05-3667-g06.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e741/6472193/47d57a698707/MMR-19-05-3667-g00.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e741/6472193/d52c430b8bf2/MMR-19-05-3667-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e741/6472193/4d0a1c7e446d/MMR-19-05-3667-g02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e741/6472193/4943dbfc2a8f/MMR-19-05-3667-g03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e741/6472193/9f5aba2a410f/MMR-19-05-3667-g04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e741/6472193/bb4b4d476d16/MMR-19-05-3667-g05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e741/6472193/03f33afb7c75/MMR-19-05-3667-g06.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e741/6472193/47d57a698707/MMR-19-05-3667-g00.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e741/6472193/d52c430b8bf2/MMR-19-05-3667-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e741/6472193/4d0a1c7e446d/MMR-19-05-3667-g02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e741/6472193/4943dbfc2a8f/MMR-19-05-3667-g03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e741/6472193/9f5aba2a410f/MMR-19-05-3667-g04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e741/6472193/bb4b4d476d16/MMR-19-05-3667-g05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e741/6472193/03f33afb7c75/MMR-19-05-3667-g06.jpg

相似文献

1
MicroRNA‑124 suppresses cell proliferation and invasion of triple negative breast cancer cells by targeting STAT3.MicroRNA-124 通过靶向 STAT3 抑制三阴性乳腺癌细胞的增殖和侵袭。
Mol Med Rep. 2019 May;19(5):3667-3675. doi: 10.3892/mmr.2019.10044. Epub 2019 Mar 15.
2
NEAT1/miR‑124/STAT3 feedback loop promotes breast cancer progression.NEAT1/miR-124/STAT3 反馈环促进乳腺癌进展。
Int J Oncol. 2019 Sep;55(3):745-754. doi: 10.3892/ijo.2019.4841. Epub 2019 Jul 15.
3
Long noncoding RNA SNHG14 promotes the aggressiveness of retinoblastoma by sponging microRNA‑124 and thereby upregulating STAT3.长链非编码 RNA SNHG14 通过海绵吸附 microRNA-124 并上调 STAT3 促进视网膜母细胞瘤的侵袭性。
Int J Mol Med. 2020 Jun;45(6):1685-1696. doi: 10.3892/ijmm.2020.4547. Epub 2020 Mar 20.
4
MicroRNA‑27a promotes tumorigenesis via targeting AKT in triple negative breast cancer.微小 RNA-27a 通过靶向三阴性乳腺癌中的 AKT 促进肿瘤发生。
Mol Med Rep. 2018 Jan;17(1):562-570. doi: 10.3892/mmr.2017.7886. Epub 2017 Oct 26.
5
STAT3 is involved in miR-124-mediated suppressive effects on esophageal cancer cells.信号转导及转录激活因子3(STAT3)参与了微小RNA-124(miR-124)对食管癌细胞的抑制作用。
BMC Cancer. 2015 Apr 19;15:306. doi: 10.1186/s12885-015-1303-0.
6
miR-199a-5p confers tumor-suppressive role in triple-negative breast cancer.miR-199a-5p在三阴性乳腺癌中发挥肿瘤抑制作用。
BMC Cancer. 2016 Nov 14;16(1):887. doi: 10.1186/s12885-016-2916-7.
7
MicroRNA-124 inhibits the proliferation of C6 glioma cells by targeting Smad4.微小 RNA-124 通过靶向 Smad4 抑制 C6 神经胶质瘤细胞的增殖。
Int J Mol Med. 2017 Oct;40(4):1226-1234. doi: 10.3892/ijmm.2017.3088. Epub 2017 Aug 3.
8
Dual Suppressive Effect of miR-34a on the FOXM1/eEF2-Kinase Axis Regulates Triple-Negative Breast Cancer Growth and Invasion.miR-34a 对 FOXM1/eEF2 激酶轴的双重抑制作用调控三阴性乳腺癌的生长和侵袭。
Clin Cancer Res. 2018 Sep 1;24(17):4225-4241. doi: 10.1158/1078-0432.CCR-17-1959. Epub 2018 May 10.
9
MiR-25-3p promotes the proliferation of triple negative breast cancer by targeting BTG2.miR-25-3p 通过靶向 BTG2 促进三阴性乳腺癌的增殖。
Mol Cancer. 2018 Jan 8;17(1):4. doi: 10.1186/s12943-017-0754-0.
10
Long noncoding RNA HOST2, working as a competitive endogenous RNA, promotes STAT3-mediated cell proliferation and migration via decoying of let-7b in triple-negative breast cancer.长链非编码 RNA HOST2 作为竞争性内源性 RNA,通过充当 let-7b 的诱饵来促进三阴性乳腺癌中 STAT3 介导的细胞增殖和迁移。
J Exp Clin Cancer Res. 2020 Apr 5;39(1):58. doi: 10.1186/s13046-020-01561-7.

引用本文的文献

1
Tumor Microenvironment Dynamics of Triple-Negative Breast Cancer Under Radiation Therapy.三阴性乳腺癌在放射治疗下的肿瘤微环境动态变化
Int J Mol Sci. 2025 Mar 20;26(6):2795. doi: 10.3390/ijms26062795.
2
Impact of microRNA variants on PI3K/AKT signaling in triple-negative breast cancer: comprehensive review.miRNA 变异对三阴性乳腺癌中 PI3K/AKT 信号的影响:全面综述。
Med Oncol. 2024 Aug 9;41(9):222. doi: 10.1007/s12032-024-02469-4.
3
Role of microRNAs in triple‑negative breast cancer and new therapeutic concepts (Review).

本文引用的文献

1
MDHGI: Matrix Decomposition and Heterogeneous Graph Inference for miRNA-disease association prediction.MDHGI:用于 miRNA 疾病关联预测的矩阵分解和异质图推理。
PLoS Comput Biol. 2018 Aug 24;14(8):e1006418. doi: 10.1371/journal.pcbi.1006418. eCollection 2018 Aug.
2
BNPMDA: Bipartite Network Projection for MiRNA-Disease Association prediction.BNPMDA:基于二分网络投影的 miRNA-疾病关联预测方法。
Bioinformatics. 2018 Sep 15;34(18):3178-3186. doi: 10.1093/bioinformatics/bty333.
3
microRNA-124 inhibits bone metastasis of breast cancer by repressing Interleukin-11.
微小RNA在三阴性乳腺癌中的作用及新治疗理念(综述)
Oncol Lett. 2024 Jul 11;28(3):431. doi: 10.3892/ol.2024.14565. eCollection 2024 Sep.
4
Mapping the function of MicroRNAs as a critical regulator of tumor-immune cell communication in breast cancer and potential treatment strategies.绘制微小RNA的功能,其作为乳腺癌中肿瘤-免疫细胞通讯的关键调节因子及潜在治疗策略。
Front Cell Dev Biol. 2024 Apr 25;12:1390704. doi: 10.3389/fcell.2024.1390704. eCollection 2024.
5
Function of microRNA‑124 in the pathogenesis of cancer (Review).微小 RNA-124 在癌症发病机制中的功能(综述)。
Int J Oncol. 2024 Jan;64(1). doi: 10.3892/ijo.2023.5594. Epub 2023 Dec 1.
6
Molecular Biology Mechanisms and Emerging Therapeutics of Triple-Negative Breast Cancer.三阴性乳腺癌的分子生物学机制与新兴治疗方法
Biologics. 2023 Sep 21;17:113-128. doi: 10.2147/BTT.S426392. eCollection 2023.
7
Peripheral mRNA Expression and Prognostic Significance of Emotional Stress Biomarkers in Metastatic Breast Cancer Patients.转移性乳腺癌患者外周血 mRNA 表达与情绪应激生物标志物的预后意义。
Int J Mol Sci. 2022 Nov 15;23(22):14097. doi: 10.3390/ijms232214097.
8
Regulation of the Key Epithelial Cancer Suppressor miR-124 Function by Competing Endogenous RNAs.竞争内源性 RNA 对关键上皮癌抑制 miR-124 功能的调控。
Int J Mol Sci. 2022 Nov 7;23(21):13620. doi: 10.3390/ijms232113620.
9
MiR-223-3p attenuates the migration and invasion of NSCLC cells by regulating NLRP3.微小RNA-223-3p通过调控NLRP3减轻非小细胞肺癌细胞的迁移和侵袭。
Front Oncol. 2022 Oct 6;12:985962. doi: 10.3389/fonc.2022.985962. eCollection 2022.
10
STAT family of transcription factors in breast cancer: Pathogenesis and therapeutic opportunities and challenges.STAT 家族转录因子在乳腺癌中的作用:发病机制及治疗的机遇与挑战。
Semin Cancer Biol. 2022 Nov;86(Pt 3):84-106. doi: 10.1016/j.semcancer.2022.08.003. Epub 2022 Aug 19.
microRNA-124 通过抑制白细胞介素-11 抑制乳腺癌骨转移。
Mol Cancer. 2018 Jan 17;17(1):9. doi: 10.1186/s12943-017-0746-0.
4
LRSSLMDA: Laplacian Regularized Sparse Subspace Learning for MiRNA-Disease Association prediction.LRSSLMDA:用于miRNA-疾病关联预测的拉普拉斯正则化稀疏子空间学习
PLoS Comput Biol. 2017 Dec 18;13(12):e1005912. doi: 10.1371/journal.pcbi.1005912. eCollection 2017 Dec.
5
MiR-93-5p inhibits the EMT of breast cancer cells via targeting MKL-1 and STAT3.微小RNA-93-5p通过靶向肌动蛋白结合蛋白1和信号转导与转录激活因子3抑制乳腺癌细胞的上皮-间质转化。
Exp Cell Res. 2017 Aug 1;357(1):135-144. doi: 10.1016/j.yexcr.2017.05.007. Epub 2017 May 9.
6
MiRNA-29b suppresses tumor growth through simultaneously inhibiting angiogenesis and tumorigenesis by targeting Akt3.miRNA-29b 通过靶向 Akt3 同时抑制血管生成和肿瘤发生来抑制肿瘤生长。
Cancer Lett. 2017 Jul 1;397:111-119. doi: 10.1016/j.canlet.2017.03.032. Epub 2017 Mar 29.
7
Her-2 expression regulated by downregulation of miR-9 and which affects chemotherapeutic effect in breast cancer.miR-9 下调调控 Her-2 表达并影响乳腺癌的化疗效果。
Cancer Gene Ther. 2017 May;24(5):194-202. doi: 10.1038/cgt.2014.82. Epub 2017 Mar 31.
8
miR-455 inhibits breast cancer cell proliferation through targeting CDK14.miR-455 通过靶向 CDK14 抑制乳腺癌细胞增殖。
Eur J Pharmacol. 2017 Jul 15;807:138-143. doi: 10.1016/j.ejphar.2017.03.016. Epub 2017 Mar 11.
9
MicroRNAs regulate the epithelial-mesenchymal transition and influence breast cancer invasion and metastasis.微小RNA调控上皮-间质转化并影响乳腺癌的侵袭和转移。
Tumour Biol. 2017 Feb;39(2):1010428317691682. doi: 10.1177/1010428317691682.
10
Downregulation of miRNA-141 in breast cancer cells is associated with cell migration and invasion: involvement of ANP32E targeting.乳腺癌细胞中miRNA-141的下调与细胞迁移和侵袭相关:涉及对ANP32E的靶向作用。
Cancer Med. 2017 Mar;6(3):662-672. doi: 10.1002/cam4.1024. Epub 2017 Feb 21.